Artwork

Content provided by Medical Product Outsourcing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medical Product Outsourcing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Femasys Targets Fertility and Women’s Health

14:44
 
Share
 

Manage episode 316785547 series 2805302
Content provided by Medical Product Outsourcing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medical Product Outsourcing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Kathy Lee-Sepsick, founder and CEO of Femasys. She provides an overview of how the company’s technology is helping women who are dealing with infertility. She also speaks about a device that enables a non-surgical means of permanent birth control. Specifically, the following questions are addressed.

  • Can you please start off by giving us a little insight on what Femasys is?
  • So your technologies are at both end of the spectrum, addressing infertility and also helping to prevent pregnancy. Can you talk a bit about the FemaSeed and how it different from other available infertility technologies?
  • What is FemBlock and how does it work?
  • What is FemVue and how did it change the current standard for this type of medicine?
  • What’s next for Femasys? Where is the firm headed?

Listen to this episode and see what you think of the women’s health technologies from Femasys. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Send us a text

For more medtech news and information, visit www.mpomag.com.

  continue reading

144 episodes

Artwork
iconShare
 
Manage episode 316785547 series 2805302
Content provided by Medical Product Outsourcing. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medical Product Outsourcing or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Kathy Lee-Sepsick, founder and CEO of Femasys. She provides an overview of how the company’s technology is helping women who are dealing with infertility. She also speaks about a device that enables a non-surgical means of permanent birth control. Specifically, the following questions are addressed.

  • Can you please start off by giving us a little insight on what Femasys is?
  • So your technologies are at both end of the spectrum, addressing infertility and also helping to prevent pregnancy. Can you talk a bit about the FemaSeed and how it different from other available infertility technologies?
  • What is FemBlock and how does it work?
  • What is FemVue and how did it change the current standard for this type of medicine?
  • What’s next for Femasys? Where is the firm headed?

Listen to this episode and see what you think of the women’s health technologies from Femasys. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Send us a text

For more medtech news and information, visit www.mpomag.com.

  continue reading

144 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide